219 related articles for article (PubMed ID: 9790359)
1. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease.
Hudon L; Moise KJ; Hegemier SE; Hill RM; Moise AA; Smith EO; Carpenter RJ
Am J Obstet Gynecol; 1998 Oct; 179(4):858-63. PubMed ID: 9790359
[TBL] [Abstract][Full Text] [Related]
2. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
3. Management of severe hemolytic disease with ultrasound-guided intravascular fetal transfusions.
Kanhai HH; Bennebroek Gravenhorst J; van Kamp IL; Meerman RH; Brand A; Dohmen-Feld MW; Ruys JH
Vox Sang; 1990; 59(3):180-4. PubMed ID: 2264321
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection.
Nagel HT; de Haan TR; Vandenbussche FP; Oepkes D; Walther FJ
Obstet Gynecol; 2007 Jan; 109(1):42-7. PubMed ID: 17197586
[TBL] [Abstract][Full Text] [Related]
5. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
[TBL] [Abstract][Full Text] [Related]
6. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.
Lindenburg IT; Smits-Wintjens VE; van Klink JM; Verduin E; van Kamp IL; Walther FJ; Schonewille H; Doxiadis II; Kanhai HH; van Lith JM; van Zwet EW; Oepkes D; Brand A; Lopriore E;
Am J Obstet Gynecol; 2012 Feb; 206(2):141.e1-8. PubMed ID: 22030316
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
[TBL] [Abstract][Full Text] [Related]
8. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization.
Goodrum LA; Saade GR; Belfort MA; Carpenter RJ; Moise KJ
Obstet Gynecol; 1997 Jan; 89(1):57-60. PubMed ID: 8990438
[TBL] [Abstract][Full Text] [Related]
9. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia.
Grannum PA; Copel JA; Moya FR; Scioscia AL; Robert JA; Winn HN; Coster BC; Burdine CB; Hobbins JC
Am J Obstet Gynecol; 1988 Apr; 158(4):914-9. PubMed ID: 3284364
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
[TBL] [Abstract][Full Text] [Related]
11. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
[TBL] [Abstract][Full Text] [Related]
12. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
13. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
Lobato G; Nakamura-Pereira M
Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
[TBL] [Abstract][Full Text] [Related]
14. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops.
Dembinski J; Haverkamp F; Maara H; Hansmann M; Eis-Hübinger AM; Bartmann P
BJOG; 2002 Nov; 109(11):1232-4. PubMed ID: 12452460
[TBL] [Abstract][Full Text] [Related]
16. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism.
Janssens HM; de Haan MJ; van Kamp IL; Brand R; Kanhai HH; Veen S
J Pediatr; 1997 Sep; 131(3):373-80. PubMed ID: 9329412
[TBL] [Abstract][Full Text] [Related]
17. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
18. Pulsed Doppler flow-velocity waveforms before and after intrauterine intravascular transfusion for severe erythroblastosis fetalis.
Copel JA; Grannum PA; Belanger K; Green J; Hobbins JC
Am J Obstet Gynecol; 1988 Apr; 158(4):768-74. PubMed ID: 2966585
[TBL] [Abstract][Full Text] [Related]
19. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
20. Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years.
Grab D; Paulus WE; Bommer A; Buck G; Terinde R
Obstet Gynecol; 1999 Feb; 93(2):165-8. PubMed ID: 9932548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]